Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic.
J Law Med Ethics
; 50(S1): 8-23, 2022.
Article
in English
| MEDLINE | ID: covidwho-2266361
ABSTRACT
The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
HIV Infections
/
Epidemics
/
Pre-Exposure Prophylaxis
Type of study:
Observational study
Limits:
Humans
Language:
English
Journal:
J Law Med Ethics
Journal subject:
Nursing
/
Ethics
/
Jurisprudence
/
Medicine
/
Health Services Research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS